Literature DB >> 19870377

STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : II. OBSERVATIONS ON THE PROTECTIVE MECHANISM AGAINST THE VIRULENT VARIANTS.

C Lyons1, H K Ward.   

Abstract

1. Anantiserum which specifically protects mice against a virulent culture (M variant) of the hemolytic streptococcus contains specific opsonin. Phagocytosis of the organisms can be observed in the peritoneum of the protected mouse. 2. An antiserum prepared by injecting an animal with the living M variant specifically opsonizes both the F and the M variant of the strain. 3. Evidence is presented which indicates the probable identity of the specific opsonin and the anti-M precipitin of Lancefield (7). Agglutination appears to be dependent upon a different antibody. 4. It is possible to type the hemolytic streptococci by means of specific opsonins, and the opsonic method has certain advantages over agglutination, precipitation, and mouse protection tests. It is evident from what little has been done that there are many types. 5. The serum of infants contains no opsonin for the virulent hemolytic streptococci, but the serum of adults may contain specific opsonins for certain strains. Inasmuch as no opsonins were demonstrable in two polyvalent antibacterial sera examined, the possibilities of therapeutic transfusion are discussed.

Entities:  

Year:  1935        PMID: 19870377      PMCID: PMC2133234          DOI: 10.1084/jem.61.4.531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Capsules in Young Cultures of Streptococcus hemolyticus.

Authors:  C V Seastone
Journal:  J Bacteriol       Date:  1934-11       Impact factor: 3.490

2.  STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  A R Dochez; O T Avery; R C Lancefield
Journal:  J Exp Med       Date:  1919-09-01       Impact factor: 14.307

3.  AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS.

Authors:  H K Ward; J F Enders
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

4.  STUDIES ON INFLAMMATION : IX. A FACTOR IN THE MECHANISM OF INVASIVENESS BY PYOGENIC BACTERIA.

Authors:  V Menkin
Journal:  J Exp Med       Date:  1933-05-31       Impact factor: 14.307

5.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett; R L Garner
Journal:  J Exp Med       Date:  1933-09-30       Impact factor: 14.307

6.  OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : I. THE NORMAL PHAGOCYTIC TITRE, AND THE ANTI-PHAGOCYTIC EFFECT OF THE SPECIFIC SOLUBLE SUBSTANCE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1930-04-30       Impact factor: 14.307

7.  ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.

Authors:  R C Lancefield; E W Todd
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

  7 in total
  6 in total

1.  Recurrent sepsis caused by Streptococcus pyogenes.

Authors:  Magnus Rasmussen
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

2.  THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  E H Kass; C V Seastone
Journal:  J Exp Med       Date:  1944-03-01       Impact factor: 14.307

3.  TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

4.  THE OCCURRENCE OF MUCOID POLYSACCHARIDE IN HEMOLYTIC STREPTOCOCCI OF HUMAN ORIGIN.

Authors:  C V Seastone
Journal:  J Exp Med       Date:  1943-01-01       Impact factor: 14.307

5.  Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

6.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.